The Korean Journal of Nuclear Medicine (대한핵의학회지)
- Volume 30 Issue 1
- /
- Pages.65-76
- /
- 1996
- /
- 1225-6714(pISSN)
Thyrotropin-Binding Inhibiting Immunoglobulin(TBII) in Patients with Autoimmune Thyroid Diseases
자가면역성 갑상선질환에서의 혈청 Thyrotropin-Binding Inhibiting Immunoglobulin치
- Jang, Dae-Sung (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
-
Ahn, Byeong-Cheol
(Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
- Sohn, Sang-Kyun (Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
-
Lee, Jae-Tae
(Department of Nuclear Medicine, School of Medicine, Kyungpook National University) ;
- Lee, Kyu-Bo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
- 장대성 (경북대학교 의과대학 핵의학교실) ;
-
안병철
(경북대학교 의과대학 핵의학교실) ;
- 손상균 (경북대학교 의과대학 핵의학교실) ;
-
이재태
(경북대학교 의과대학 핵의학교실) ;
- 이규보 (경북대학교 의과대학 핵의학교실)
- Published : 1996.03.25
Abstract
In order to evaluate the significance of thyrotropin-binding inhibiting immunoglobulin (TBII) in the patients with autoimmune thyroid diseases, the authors investigated 402 cases of Graves' disease and 230 cases of Hashimoto's thyroiditis comparing 30 cases of normal healthy adult at Kyung Pook University Hospital from February 1993 to August 1994. The TBII was tested by radioimmunoassay and assesed on the dynamic change with the disease course, thyroid functional parameters, and other thyroid autoantibodies : antithyroglobulin antibody (ATAb) and antimicrosomal antibody (AMAb) including thyroglobulin. The serum level of TBII was
1993년 2월부터 1994년 8월까지 경북대학교병원 핵의학과에서 진료한 갑상선질환 중 그레이브스병 402예와 하시모토갑상선염 230예를 대상으로 혈청 thyrotropin-binding inhibiting immunoglobulin (TBII)치를 방사면역측정법으로 측정하여 갑상선 기능상태와 그 치료경과에 있어서의 동태를 관찰하고 아울러 혈청 갑상선글로블린치, antithyroglobulin anti-body(ATAb) 및 antimicrosomal antibody(AMAb)의 동태를 동시에 검토하여 다음과 같은 결과를 얻었다. 혈청 TBII치는 갑상선기능항진성 그레이브스병에서 평균